ArticleHaematologica2016

Comment on Lipsky et al.: Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.

Constantine S Tam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.